To include your compound in the COVID-19 Resource Center, submit it here.

Interleukin Genetics, Molecular Skin, University of Sheffield deal

ILGN received about 5% of the outstanding equity of Molecular

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE